Skip to main content

Advertisement

Log in

Post-traumatic headache

  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

  • Headache is the most common symptom after closed head injury, persisting for more than 2 months in 60% of patients [1]. Rarely does headache occur in isolation. Cervical pain is a frequent accompaniment. Post-traumatic headache is often one of several symptoms of the postconcussive syndrome, and therefore may be accompanied by additional cognitive, behavioral, and somatic problems.

  • Acute post-traumatic headaches may begin at the time of injury and continue for up to 2 months post-injury. Although onset proximate to the time of injury is most common, any new headache type occurring within this period of time is referred to as an acute post-traumatic headache. If such headaches persist beyond the first two months post-injury, they are subsequently referred to as chronic post-traumatic headaches. Over time, post-traumatic headaches may take on a pattern of daily occurrence. If aggressive treatment is initiated early, posttraumatic headache is less likely to become a permanent problem. Once “windup” of post-traumatic headaches occurs, the cycle of ongoing headaches is more difficult to interrupt.

  • The mechanism of post-traumatic headache is poorly understood. Trauma-induced headaches are usually heterogeneous in nature, often including both tension-type pain and intermittent migraine-like attacks. Rebound-headaches may develop from overuse of analgesic medications, and the occurrence of such may complicate significantly the diagnosis of post-traumatic headache.

  • Adequate treatment typically requires both “peripheral” and “central” measures. Understanding the general principles of treatment, especially appropriate use of preventive and abortive medications, will most usefully guide treatment. There is scant literature with which to direct treatment selection for post-traumatic headache. Consequently, treatments for post-traumatic headache are based on those prescribed for phenomenologically similar but etiologically distinct headache disorders.

  • Delayed recovery from post-traumatic headache may be a result of inadequately aggressive or ineffective treatment, overuse of analgesic medications resulting in analgesia rebound phenomena, or comorbid psychiatric disorders (eg, post-traumatic stress disorder, insomnia, substance abuse, depression, or anxiety).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Saper J, Silberstein S, Gordon C, Hamel R: Handbook of Headache Management.ed 2, Baltimore: Williams and Wilkins; 2000. This is the most useful reference for physicians in managing headache issues.

    Google Scholar 

  2. Haas D: Chronic post-traumatic headaches classified and compared with natural headaches. Cephalalgia 1996, 16:486–493.

    Article  PubMed  CAS  Google Scholar 

  3. Packard R, Ham L: Pathogenesis of post-traumatic headache and migraine: a common headache pathway? Headache 1997, 37:142–152.

    Article  PubMed  CAS  Google Scholar 

  4. Bogduk N, Jensen R: Anatomy and pathology of tension-type headache. In The Headaches, edn 2. Edited by Olsen J, Tfelt-Hansen P, Welch KMA. Philadelphia: Lippincott Williams and Wilkins; 2000:551–559.

    Google Scholar 

  5. Duke University Center for Clinical Health Policy Research: Drug treatments for the prevention of migraine headache. In Technical Review 2.3. Rockville: Agency for Health Care Policy and Research; 1999:6.

    Google Scholar 

  6. Silberstein S, Goadsby P: Migraine Prevention. Applying Evidence-Based Medicine to Clinical Practice. Philadelphia, PA: Office of Continuing Medical Education, Jefferson Medical College; 2000. This up-to-date review of treatment based on clinical research that also offers tips on setting up a complete headache treatment program.

    Google Scholar 

  7. Rapoport A, Weeks R: Analgesic rebound headache. In Headache: A Clinicians Guide to Diagnosis, Pathophysiology and Treatment Strategies. Edited by Rapoport A, Sheftell F. Los Alamitos, CA: PMA Publishing Corp; 1993:157–165.

    Google Scholar 

  8. Packard RC, Ham LP: Post-traumatic Headache. Semin Headache Manage 1997; 2:1–4. This article includes definitions, epidemiology, mechanism, evaluation, management, prognosis, and review of legal issues.

    Google Scholar 

  9. Packard RC: Post-traumatic headache: permanency and relationship to legal settlement. Headache 1992, 32:496–500.

    Article  PubMed  CAS  Google Scholar 

  10. Packard RC: What does the headache patient want? Headache 1979, 19:370–374.

    Article  PubMed  CAS  Google Scholar 

  11. Tfelt-Hansen P, Welch KMA: Prioritizing prophylactic treatment of migraine. In The Headaches, edn 2. Edited by Olsen J, Tfelt-Hansen P, Welch KMA. Philadelphia: Lippincott Williams and Wilkins; 2000:499–500.

    Google Scholar 

  12. Markley H, Cheronis J, Piepho R: Verapamil and prophylactic therapy of migraine. Neurology 1984, 34:973–976.

    PubMed  CAS  Google Scholar 

  13. Solomon G, Steel J, Spaccavento L: Verapamil prophylaxis of migraine: a double blind, placebocontrolled study. JAMA 1983, 250:2500–2502.

    Article  PubMed  CAS  Google Scholar 

  14. Leandri M, Rigargo S, Schizzi R, Parodi C: Migraine treatment with nicardipine. Cephalalgia 1990, 10:111–116.

    Article  PubMed  CAS  Google Scholar 

  15. Tfelf-Hansen P, Standnes B, Kangasniemi P, et al.: Timolol versus propranolol versus placebo in common migraine prophylaxis: a double-blind multicenter trial. Acta Neurol Scand 1984, 69:1–8.

    Google Scholar 

  16. Borgesen S: Treatment of migraine with propranolol. Postgrad Med J 1976, 52(suppl):163–165.

    PubMed  Google Scholar 

  17. Weber R, Reinmuth O: The treatment of migraine with propranolol. Neurology 1972, 22:366–369.

    PubMed  CAS  Google Scholar 

  18. Tyler G, McNeely H, Dick M: Treatment of posttraumatic headache with amitriptyline. Headache 1980, 20:213–216.

    Article  PubMed  CAS  Google Scholar 

  19. Label L: Treatment of post-traumatic headache: maprotiline or amitriptyline [poster]? Neurology 1991, 41(suppl):247.

    Google Scholar 

  20. Saran A: Antidepressants not effective in headache associated with minor closed head injury. Int J Psychiatry Med 1988, 18:75–83.

    Article  PubMed  CAS  Google Scholar 

  21. Saper JR, Lake AE, Tepper SJ: Nefazodone for chronic daily headache prophylaxis: an open label study. Headache 2001, 41:465–474.

    Article  PubMed  CAS  Google Scholar 

  22. Adelman L, Adelman J, Von Seggern R, Mannix L: Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: a retrospective study in a clinical setting. Headache 2000, 40:572–580.

    Article  PubMed  CAS  Google Scholar 

  23. Wroblewski BA, McColgan K, Smith K, et al.: The incidence of seizures during tricyclic antidepressant drug treatment in a brain-injured population. J Clin Psychopharmacol 1990, 10:124–128.

    Article  PubMed  CAS  Google Scholar 

  24. Mathew N: Diagnosis and modern treatment of migraine. Progr Neurology 1999, 1:3–24. A complete update on migraine.

    Google Scholar 

  25. Mathew N, Saper J, Silberstein S, et al.: Migraine prophylaxis with divalproex. Arch Neurol 1995, 52:281–286.

    PubMed  CAS  Google Scholar 

  26. Packard RC: Treatment of chronic daily headache with divalproex sodium. Headache 2000, 40:736–739.

    Article  PubMed  CAS  Google Scholar 

  27. Di Trapini G, Mei D, Marra S, Capuano A: Gabapentin in the prophylaxis of migraine: a double-blind randomized placebo-controlled study. Clinica Therapeutica 2000, 151:145–148.

    Google Scholar 

  28. Wheeler S, Carrazana E: Topirimate-treated cluster headache. Neurology 1999, 53:234–236.

    PubMed  CAS  Google Scholar 

  29. Potter D, Hart D, Calder C, Storey J: A double-blind, randomized, placebo-controlled study of topirimate in the prophylactic treatment of migraine with and without aura. Cephalalgia 2000, 20:305.

    Article  Google Scholar 

  30. Shuaib A: Efficacy of topirimate in prophylaxis of frequent severe migraines or chronic daily headaches: experience with 68 patients over 18 months. Cephalalgia 2000, 20:423.

    Google Scholar 

  31. Lindegaard K, Ovrelid L, Sjaastad O: Naproxen in the prevention of migraine attacks: a double-blind placebo-controlled cross-over study. Headache 1980, 20:96–98.

    Article  PubMed  CAS  Google Scholar 

  32. Solomon S, Newman LC: Chronic daily bilateral headache responsive to indomethacin. Headache 1999, 39:754–757.

    Article  PubMed  CAS  Google Scholar 

  33. Hannerz J: Chronic bilateral headache responding to indomethacin. Headache 2000, 40:840–843.

    Article  PubMed  CAS  Google Scholar 

  34. Antonaci F, Pareja JA, Caminero AB, Sjaastad O: Chronic paroxysmal hemicrania and hemicrania continua. Parenteral indomethacin: the indotest. Headache 1998, 38:122–128.

    Article  PubMed  CAS  Google Scholar 

  35. Sjaastad O, Spierings EL: Hemicrania continua: another headache absolutely responsive to indomethacin. Cephalalgia 1984, 4:65–70.

    Article  PubMed  CAS  Google Scholar 

  36. Geaney DP: Indomethacin-responsive episodic cluster headache. J Neurology Neurosurgery Psychiatry 1983, 46:860–861.

    CAS  Google Scholar 

  37. Medina JL: Organic headaches mimicking chronic paroxysmal hemicrania. Headache 1992, 32:73–74.

    Article  PubMed  CAS  Google Scholar 

  38. Saper J, Winner P, Lake A: The safety and efficacy of tizanidine HCl in prophylaxis of chronic daily headaches [poster]. Montreal, Canada: American Headache Society; 2000.

    Google Scholar 

  39. Murros K, Kataja M, Hedman C, et al.: Modified release formulation of tizanadine in chronic tension type headache. Headache 2000, 40:633–637.

    Article  PubMed  CAS  Google Scholar 

  40. Mathew N, Schoenen J: Acute pharmacology of tension type headache. In The Headaches, edn 2. Edited by Olsen J, Tfelt-Hansen P, Welch KMA. Philadelphia: Lippincott Williams and Wilkins; 2000:661–666.

    Google Scholar 

  41. Tfelt-Hansen P, McEwen J: Nonsteroidal antiinflammatory drugs in the acute treatment of migraine. In The Headaches, edn 2. Edited by Olsen J, Tfelt-Hansen P, Welch KMA. Philadelphia: Lippincott Williams and Wilkins; 2000:391–397.

    Google Scholar 

  42. Davis C, Torre P, Williams C: Ketorolac versus meperidine-plus-promethazine treatment of migraine headache: evaluation by patients. Am J Emerg Med 1995, 13:146–150.

    Article  PubMed  CAS  Google Scholar 

  43. Ryan R: A study of midrin in the symptomatic relief of migraine headache. Headache 1974, 14:33–42.

    Article  PubMed  CAS  Google Scholar 

  44. Saxena PR, Tfelt-Hansen P: Triptans, 5-HT1B and 1D receptor agonists in the acute treatment of migraine. In The Headaches, edn 2. Edited by Olsen J, Tfelt-Hansen P, Welch KMA. Philadelphia: Lippincott Williams and Wilkins; 2000:411–438.

    Google Scholar 

  45. American Academy of Neurology: American Academy of Neurology Headache Guidelines. Accessed at: http://www.aan.org.

  46. Gallagher R: Acute treatment of migraine with dihydroergotamine nasal spray. Arch Neurol 1996, 53:1285–1291.

    PubMed  CAS  Google Scholar 

  47. Winner P, Ricalde O, Le Force B, et al.: A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine. Arch Neurol 1996, 53:180–184.

    PubMed  CAS  Google Scholar 

  48. Mc Beath J, Nanda A: Use of dihydroergotamine in patients with postconcussion syndrome. Headache 1994, 34:148–151.

    Article  CAS  Google Scholar 

  49. Carlsson J, Jensen R: Physiotherapy of tension-type headache. In The Headaches, 2nd ed. Edited by: Olsen J, Tfelt-Hansen P, Welch KMA. Philadelphia: Lippincott Williams and Wilkins; 2000:651–656.

    Google Scholar 

  50. Packard RC: Epidemiology and pathogenesis of post-traumatic headache. J Head Trauma Rehabil 1999, 14:9–21.

    PubMed  CAS  Google Scholar 

  51. Hickling E, Blanchard E, Silverman D, Schwarz S: Motor vehicle accidents, headaches and post-traumatic stress disorder: assessment and findings in a consecutive series. Headache 1992, 32:147–151.

    Article  PubMed  CAS  Google Scholar 

  52. Wheeler A: Botulinum toxin A adjunctive therapy for refractory headache associated with pericranial muscle tension. Headache 1998, 38:468–471.

    Article  PubMed  CAS  Google Scholar 

  53. Schulte-Mattler W, Wiesler T, Zierz S: Treatment of tension type headache with botulinum toxin: a pilot study. Eur J Med Res 1999, 4:183–186.

    PubMed  CAS  Google Scholar 

  54. Carruthers A, Langtry J, Robinson G: Improvement of tension-type headache when treating wrinkles with botulinum toxin A injections. Headache 1999, 39:662–665.

    Article  PubMed  CAS  Google Scholar 

  55. Freund B, Schwartz M: Treatment of chronic cervicalassociated headache with botulinum toxin A: a pilot study. Headache 2000, 40:231–236.

    Article  PubMed  CAS  Google Scholar 

  56. Rollnik J, Tanneberger O, Schubert M, Schneider U, Dengler R: Treatment of tension-type headache with botulinum toxin A: a double-blind, placebocontrolled study. Headache 2000, 40:300–305.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lane, J.C., Arciniegas, D.B. Post-traumatic headache. Curr Treat Options Neurol 4, 89–104 (2002). https://doi.org/10.1007/s11940-002-0007-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-002-0007-3

Keywords

Navigation